The purpose of the present study was to evaluate the immunohistochemical expression of panCD44 in neoplastic and nonneoplastic prostate epithelium, determining its association with tumor aggressiveness (preoperative PSA level, Gleason score, tumor stage, surgical margin status, and biochemical recurrence) and C-MYC expression. The gene discussed is MYC; the disease is neoplasm.